ANIP ANI PHARMACEUTICALS INC Capital Structure Changes 8-K Filing 2025 - Rights Offerings ANI Pharmaceuticals filed a proxy supplement on May 6, 2025, to clarify details related to their Amended and Restated 2022 Stock Incentive Plan, indicating a total of 1,177,800 shares remain for future grants as of March 24, 2025. As of that date, their stock was trading at $65.98 per share.Get access to all SEC 8-K filings of the ANI PHARMACEUTICALS INC